Weimin Yao Selected Research

Weimin Yao Research Topics

Disease

12	Neoplasms (Cancer) 02/2023 - 01/2013
7	Renal Cell Carcinoma (Grawitz Tumor) 02/2023 - 12/2014
5	Osteoporosis 03/2024 - 09/2017
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 07/2010
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2024 - 02/2018
4	Kidney Neoplasms (Kidney Cancer) 04/2022 - 10/2014
3	Fibrosis (Cirrhosis) 11/2021 - 02/2018
3	Carcinogenesis 01/2021 - 01/2019
3	Urinary Bladder Neoplasms (Bladder Cancer) 06/2019 - 09/2014
3	Neoplasm Metastasis (Metastasis) 01/2015 - 06/2014
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2019
2	Kidney Calculi (Kidney Stone) 01/2022 - 01/2014
2	Pneumonia (Pneumonitis) 11/2018 - 02/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2017 - 10/2015
1	Glanders 01/2023
1	Hydronephrosis 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020
1	Chronic Disease (Chronic Diseases) 08/2020
1	Atrial Fibrillation 10/2019
1	Hypertension (High Blood Pressure) 10/2019
1	Stroke (Strokes) 10/2019
1	Leukemia 01/2019
1	Obstructive Lung Diseases (Obstructive Lung Disease) 11/2018
1	Lung Injury 02/2018
1	Body Weight (Weight, Body) 01/2018
1	Plasmacytoma 10/2017
1	Pulmonary Embolism 07/2017
1	Carcinoma (Carcinomatosis) 01/2016
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Non-Muscle Invasive Bladder Neoplasms 09/2014
1	Intraoperative Complications 06/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2014

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2014
4	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2014
3	GlucocorticoidsIBA 03/2024 - 09/2017
3	8-hydroxyguanineIBA 01/2024 - 10/2020
3	DNA Glycosylases (DNA Glycosylase)IBA 01/2024 - 12/2017
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2024 - 02/2018
3	RNA Precursors (Precursor, mRNA)IBA 04/2022 - 01/2017
3	Long Noncoding RNAIBA 01/2020 - 10/2017
3	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2014
2	EnzymesIBA 01/2024 - 10/2015
2	Heterogeneous Nuclear Ribonucleoprotein A1IBA 02/2023 - 06/2020
2	Histones (Histone)IBA 01/2019 - 01/2019
2	MethyltransferasesIBA 01/2019 - 01/2019
2	Lysine (L-Lysine)FDA Link 01/2019 - 01/2019
2	Prednisone (Sone)FDA LinkGeneric 01/2018 - 09/2017
2	Competitive Endogenous RNAIBA 10/2017 - 12/2014
2	Small Interfering RNA (siRNA)IBA 01/2015 - 12/2014
1	Ribosomal DNA (rDNA)IBA 01/2024
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	ginsenoside M1IBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2023
1	NitritesIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 11/2021
1	CollagenIBA 11/2021
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 11/2021
1	Interleukin-8 (Interleukin 8)IBA 11/2021
1	Heparin (Liquaemin)FDA LinkGeneric 11/2021
1	gamma Catenin (Plakoglobin)IBA 01/2021
1	DNA Repair EnzymesIBA 10/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2020
1	indium-bleomycinIBA 10/2020
1	cycloastragenolIBA 08/2020
1	Galactose (Galactopyranose)FDA LinkGeneric 08/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 08/2020
1	Vitamin K FDA Link 10/2019
1	AnticoagulantsIBA 10/2019
1	Warfarin (Coumadin)FDA LinkGeneric 10/2019
1	Trans-Activators (Trans-Acting Factor)IBA 10/2019
1	Taurine FDA Link 06/2019
1	Cisplatin (Platino)FDA LinkGeneric 06/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	CytokinesIBA 02/2018
1	NickelIBA 02/2018
1	IonsIBA 02/2018
1	Alkaline PhosphataseIBA 01/2018
1	Procollagen Type IIBA 01/2018
1	Oxidants (Oxidizing Agents)IBA 12/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2017
1	Bevacizumab (Avastin)FDA Link 07/2017
1	RNA Splicing FactorsIBA 01/2017
1	Bronchodilator Agents (Bronchodilators)IBA 01/2017
1	GoldIBA 01/2017
1	Tiotropium Bromide (Spiriva)FDA Link 01/2017
1	YSL-12IBA 01/2016
1	diacetyldichlorofluoresceinIBA 10/2015
1	Mitochondrial DNA (mtDNA)IBA 10/2015
1	LuciferasesIBA 10/2014
1	Extracellular Matrix ProteinsIBA 09/2014
1	Angiogenesis InhibitorsIBA 09/2014
1	Calcium OxalateIBA 01/2014
1	Circular DNAIBA 01/2014

Therapy/Procedure

3	Therapeutics 11/2018 - 01/2016
1	Percutaneous Nephrolithotomy 01/2022
1	Castration 01/2019
1	Operative Time 06/2014